Stockholm, Sweden [March 14, 2018]: Today SwedenBio released its long-awaited “Precision Medicine – The Swedish Industry Guide 2018,” in which AMRA and its collaboration with Pfizer are presented.
In this report, the results of the first mapping of the Swedish precision medicine industry landscape are presented through a guide of 76 companies, all of which are developing innovative products and services with the potential of advancing the field. At the end of the report, there is a listing of each company’s relevant R&D projects and launched products. The report also includes:
- A map of technologies used by the companies
- Description of areas of rapid technology advancement
- Presentation of Swedish research infrastructures including Science for Life Laboratory
-
Pfizer, AstraZeneca, and Thermo Fisher Scientific views on precision medicine and their presence in Sweden
Swedish precision medicine is an area of substantial growth and, in the last four years, 26 companies were established within this area, the vast majority having 50 employees or less. These companies are strongly connected to academia, with 72% having been spun out from the academic sector and most often originating from the larger institutions: Karolinska Institutet in Stockholm, Lund University and Uppsala University.
Linköping, located within the heart of southern Sweden, has developed into a national arena for analysis of medical imaging. AMRA, which originated at Linköping University in 2010, is highlighted both as a leading company in this space, and through its close partnership with Pfizer on pages 30-31.
Download the full report here: www.swedenbio.se/reports